Jafron Biomedical Co.,Ltd. (SHE: 300529)
China flag China · Delayed Price · Currency is CNY
32.64
-0.95 (-2.83%)
Oct 11, 2024, 9:44 AM CST

Jafron Biomedical Co.,Ltd. Company Description

Jafron Biomedical Co.,Ltd. engages in the research, development, production, and sales of blood purification products for hemadsorption industry in China and internationally.

The company offers solutions for ESRD diseases, acute poisoning, critical illness, hepatopathy, immunological disorders, kidney, and liver diseases; HA series hemoperfusion cartridge, BS bilirubin adsorption column and DNA immunoadsorption column, hemoperfusion machine, and blood purification machine; and other products, such as hemodialyzer, hemodialysis concentrate, disinfectants, resin bandages, online hemodialysis powder bag/bucket, and adsorbable suture with needles.

The company was founded in 1989 and is based in Zhuhai, China.

Jafron Biomedical Co.,Ltd.
Country China
Founded 1989
Industry Medical Devices
Sector Healthcare
Employees 2,408
CEO Fan Dong

Contact Details

Address:
No. 98 Technology Six Road
Zhuhai, 519085
China
Phone 86 75 6368 9708
Website jafroninternational.com

Stock Details

Ticker Symbol 300529
Exchange Shenzhen Stock Exchange
Fiscal Year January - December
Reporting Currency CNY
ISIN Number CNE100002995
SIC Code 3842

Key Executives

Name Position
Fan Dong Chairman of Board of Directors and GM
Xueyun Liao Director and Financial Director
De Zhi Li Deputy General Manager
Xian Min Tang Deputy GM and Director
Aijun Wu Deputy General Manager
Rui Wang General Manager
Cong Huang Board Secretary